Experts are asking whether the study and treatment of myeloproliferative neoplasms (MPNs) is ready for a new era with new end ...

Explore iEUS, a deep-learning method that improves the detection of pancreatic neuroendocrine neoplasms through endoscopic ...

There can be a delay in diagnosis of myeloproliferative neoplasms as the symptoms of the diseases can be variable and common, ...

In a recent perspective published in the journal Cell Death and Differentiation, researchers in France, Germany, and Sweden ...

A cystic neoplasm needs to be considered when a patient presents with a fluid-containing pancreatic lesion. Cystic neoplasms of the pancreas may be more frequent than previously recognized and are ...

IN 1848 Bence Jones reported his unique findings in the urine of a grocer who had a malignant disease involving the bones, afterwards identified as multiple myeloma 1. Bence Jones described a ...

Discover important insights into the clonal evolution of blastic plasmacytoid dendritic cell neoplasm, a rare and aggressive ...

When given the option, patients ages 45-49 completed colorectal cancer (CRC) screening via fecal immunochemical test (FIT) at ...

In a cross-sectional study, about one third of adult survivors of childhood cancer reported clinically significant or high ...

NEW HAVEN, Conn., Oct. 08, 2024 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO) announces the launch of a new version of its Bloodhound MPN (Myeloproliferative ...

Telix Pharmaceuticals Limited (ASX: TLX, Telix, the Company) today announces that the United States (U.S.) Food and Drug Administration (FDA) has accepted the New Drug Application (NDA) for TLX101-CDx ...